TL;DR
The FDA announced a nationwide recruitment effort for scientific, technical and professional voting members, as well as consumer representatives, on advisory committees with current or expected vacancies. Nominations are accepted on a continuing basis, but the agency set November 15 and November 30, 2026, deadlines for first consideration in the two groups.
The U.S. Food and Drug Administration on September 30 announced a nationwide effort to recruit scientific experts and consumer representatives for advisory committees with current or anticipated vacancies. The agency says the committees provide independent advice on evidence concerning FDA-regulated products, and it has set separate November deadlines for nominations to receive first consideration for near-term openings.
The FDA published two notices in the Federal Register. One seeks qualified scientific, technical and professional candidates for voting-member positions across committees with current or expected vacancies. The other seeks consumer representatives, including people affiliated with or active in consumer or community-based organizations. Self-nominations are accepted, and the agency directs candidates to a centralized membership nomination portal.
Scientific and technical nominees are expected to show expertise relevant to one or more committees, the ability to interpret complex information, an understanding of public-health considerations and the capacity to offer objective, independent advice. Consumer nominees should be able to analyze technical data, discuss benefits and risks, and consider product safety and effectiveness from a public perspective.
The FDA said it is seeking candidates across multiple fields, including oncology, cardiovascular medicine, neurology, genetics and medical devices. For first consideration for current and near-term openings, consumer nominations are due by November 15, 2026; nominations for scientific, technical, professional and other voting-member roles are due by November 30. Later submissions will be considered as additional vacancies arise. Terms may be up to four years.
Who Advises the FDA on Risk
Advisory committees bring outside expertise and public perspectives into discussions of complex regulatory questions. The FDA says committee members evaluate evidence related to drugs, vaccines, biologics and medical devices, among other products, and provide recommendations that help inform agency decisions. Their advice matters to patients, consumers, health professionals and manufacturers because the issues under review can involve competing evidence about benefits, risks and safety.
The recruitment effort addresses who gets a place in those deliberations. Scientific members contribute specialized knowledge and the ability to interpret technical evidence; consumer representatives are intended to bring public-facing experience and perspectives. The agency’s stated criteria require consumer nominees to engage with technical information as well as assess products from a consumer perspective.
The announcement does not say that the recruitment drive changes how advisory committees make recommendations or how the FDA reaches final decisions. It is a call for nominations, not an announcement of appointments or a specific regulatory outcome. The practical effect will depend on who is nominated, selected and appointed, and which vacancies are filled.
medical advisory committee member guide
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How FDA Advisory Committees Fit In
The FDA describes advisory committees as groups that provide independent recommendations and scrutiny in areas where scientific and regulatory questions can be difficult or fast-moving. Their membership may include physicians, researchers, biostatisticians, patient advocates and consumer representatives. The September 30 release frames the new recruitment effort as a way to broaden participation and strengthen the range of perspectives available to the agency.
The agency’s announcement covers vacancies across committees, rather than naming a single panel or one pending product decision. It identifies a range of fields in which it is seeking expertise and directs applicants to the same nomination portal. The two Federal Register notices distinguish between voting-member nominations and nominations for consumer representatives, with different submission deadlines for first consideration.
The FDA is an agency within the U.S. Department of Health and Human Services. Its responsibilities span the regulation of human and veterinary drugs, vaccines and other biological products, medical devices, food, cosmetics, dietary supplements, radiation-emitting electronic products and tobacco products. The committees support its work by reviewing evidence and offering recommendations; the announcement does not describe them as replacing the agency’s decision-making authority.
“FDA advisory committees bring together leading scientific minds to engage with the most difficult questions in public health.”
— Kyle Diamantas, acting FDA commissioner of food and drugs
As an affiliate, we earn on qualifying purchases.
Vacancies and Appointments Still Pending
The FDA has not specified in its announcement how many seats are open or expected to become available, which individual committees will receive nominees first, or how many candidates it intends to appoint. It also has not named selected members. The release describes a nationwide nomination effort, but does not provide a target for the number or geographic distribution of nominations.
The agency says it will consider nominations on an ongoing basis, with the November dates serving as deadlines for first consideration for current and near-term vacancies. It does not set out a timetable for reviewing applications, notifying candidates or making appointments. The eventual impact on committee deliberations will depend on the selection process and the expertise and perspectives of appointed members.
The FDA announcement describes committees as providing recommendations that help inform agency decisions. It does not identify a particular pending decision that will be affected by this recruitment effort, nor does it announce changes to committee procedures. Those details are not established by the release.
FDA advisory committee nomination kit
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Nomination Deadlines and Review
Interested candidates can submit nominations through the FDA’s Advisory Committee Membership Nomination application portal. People seeking consumer representative positions should submit by November 15, 2026, for first consideration for current and near-term vacancies. Scientific, technical, professional and other voting-member nominations should be submitted by November 30 for the same consideration.
The agency says it will continue accepting nominations after both dates and consider them as later vacancies arise. The next developments will be the FDA’s review of nominations and any announcements about appointments or specific committee openings. The release gives no schedule for those decisions; candidates and the public will need to look to the agency’s notices and committee information for updates.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the FDA announce?
The FDA announced a nationwide effort to recruit scientific, technical and professional voting members, as well as consumer representatives, for advisory committees with current or expected vacancies.
What are the nomination deadlines?
For first consideration for current and near-term vacancies, consumer representative nominations are due by November 15, 2026. Scientific, technical, professional and other voting-member nominations are due by November 30, 2026.
Can people nominate themselves?
Yes. The FDA says self-nominations are accepted. Candidates can use the agency’s centralized advisory committee nomination portal.
What qualifications is the FDA seeking?
Scientific nominees should have relevant subject-matter expertise and be able to interpret technical information and provide independent advice. Consumer nominees should have experience with consumer or community organizations and be able to analyze technical data and discuss benefits, risks, safety and effectiveness from a public perspective.
Do the committees make the FDA’s final decisions?
The FDA says advisory committees provide independent recommendations that help inform agency decisions. The September 30 announcement does not say the recruitment effort changes the FDA’s decision-making authority or procedures.
Source: primary
